A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
Recruiting now · Phase 1 · Has a placebo group
Conditions studied: Atopic Dermatitis
In brief
This is a Phase 1, randomized, blinded, placebo controlled, single-ascending dose (SAD) and multiple-ascending dose (MAD) study of BBT001 in healthy volunteers (HVs) and adult patients with moderate to severe Atopic Dermatitis (AD).
Key facts
- Study ID
- NCT06808477
- Run by
- Bambusa Therapeutics
- People needed
- 237
- Starts
- 2025-02-27
- Expected to finish
- 2027-02-28
- Last updated by the study team
- 2026-07-09
Who can join
Age: 18 and older, up to 72. Sex: any. Healthy volunteers: accepted.
Where it is running
- Pacific Clinical Research Network (PCRN) - Auckland — Takapuna, Auckland, New Zealand (enrolling)
- Optimal Clinical Trials Ltd - Christchurch — Christchurch, Christchurch, New Zealand (enrolling)
- Pacific Clinical Research Network (PCRN) Wellington — Upper Hutt, New Zealand (enrolling)
- Equity Medical, LLC — The Bronx, New York, United States (enrolling)
- Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie — Rzeszów, Poland (enrolling)
- Optimal Clinical Trials Central Auckland — Grafton, Auckland, New Zealand (enrolling)
- OptiSkin Medical — New York, New York, United States (enrolling)
- Cityclinic Przychodnia Lekarsko-Psychologiczna Matusiak Spółka Partnerska — Wroclaw, Poland
- Fremantle Dermatology — Fremantle, Western Australia, Australia
- Linear Clinical Research — Perth, Western Australia, Australia
- Aotearoa Clinical Trials — Otahuhu, Auckland, New Zealand
- Wojewódzki Specjalistyczny Szpital im. Dr. Wł. Biegańskiego w Łodzi — Lodz, Poland
- Państwowy Instytut Medyczny MSWiA — Warsaw, Poland
- First OC Dermatology — Irvine, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.